(Q39992599)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4918142%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

review article

1 reference

title

Theories of biological etiology of affective disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4918142%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

Theories of Biological Etiology of Affective Disorders (English)

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

19 March 2023

author name string

J. M. Davis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4918142

19 March 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4918142

19 March 2023

publication date

1 January 1970

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4918142%20AND%20SRC:MED&resulttype=core&format=json

International Review of Neurobiology

6 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4918142%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4918142%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

page(s)

145-175

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4918142%20AND%20SRC:MED&resulttype=core&format=json

Hypertension treated with Rauwolfia serpentina (whole root) and with reserpine; controlled study disclosing occasional severe depression

6 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Effect of electroconvulsive therapy on water metabolism in psychotic patients.

19 March 2023

4

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

The variability of plasma 17-hydroxycorticosteroids—levels in affective illness and schizophrenia

19 March 2023

5

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

3-Methoxy-4-hydroxy-D-mandelic acid, a urinary metabolite of norepinephrine

19 March 2023

6

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases.

19 March 2023

7

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

3-Methoxy-4-hydroxyphenylglycol sulfate, a new metabolite of epinephrine and norepinephrine

19 March 2023

9

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Lithium as a prophylactic agents. Its effect against recurrent depressions and manic-depressive psychosis

19 March 2023

11

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Sodium-22 retention and 17-hydroxycorticosteroid excretion in affective disorders: a preliminary report

19 March 2023

12

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

19 March 2023

15

18

369

Bertler

1966

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

5-hydroxytryptamine uptake by rat brain

19 March 2023

16

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Reaction of the adrenal cortex to emotional stress.

19 March 2023

17

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Psychological stress and endocrine functions; blood levels of adrenocortical and thyroid hormones in acutely disturbed patients.

19 March 2023

18

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Suicide following cortisone treatment

19 March 2023

20

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients.

19 March 2023

21

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

The diurnal rhythm of plasma cortisol concentration in depression

19 March 2023

22

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Plasma II-Hydroxycorticosteroids in Affective Disorders

19 March 2023

24

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Fluid distribution and the response of depression to E.C.T. and imipramine.

19 March 2023

25

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

17-Ketosteroid excretion in a case of manic-depressive psychosis.

19 March 2023

26

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

A dualistic approach to some biochemical problems in endogenous depressions

19 March 2023

27

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Norepinephrine in depressive reactions. A review

19 March 2023

28

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

POSSIBILITY OF A BIOCHEMICAL TEST FOR SUICIDAL POTENTIAL: AN ANALYSIS OF ENDOCRINE FINDINGS PRIOR TO THREE SUICIDES.

19 March 2023

29

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

STUDY OF A PATIENT WITH 48-HOUR MANIC-DEPRESSIVE CYCLES. II. STRONG POSITIVE CORRELATION BETWEEN ENDOCRINE FACTORS AND MANIC DEFENSE PATTERNS.

19 March 2023

31

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

CORRELATIONS BETWEEN BEHAVIORAL VARIABLES AND URINARY 17-HYDROXYCORTICOSTEROIDS IN DEPRESSED PATIENTS.

19 March 2023

33

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Biochemical changes in psychotic depression. High norepinephrine levels in psychotic vs neurotic depression.

19 March 2023

34

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Pituitary-adrenal function in severe depressive illness.

19 March 2023

35

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

The relationship between dextran precipitable fibrinogen and 170H corticosteroid levels in psychotic subjects

19 March 2023

39

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists

19 March 2023

41

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Resistance to suppression by dexamethasone of plasma 11-O.H.C.S. levels in severe depressive illness.

19 March 2023

42

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Preliminary observations on mental disturbances occurring in patients under therapy with cortisone and ACTH.

19 March 2023

43

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Further observations on mental disturbances associated with cortisone and ACTH therapy.

19 March 2023

44

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Some clinical changes in behavior accompanying endocrine disorders.

19 March 2023

46

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Effect of Lithium on the Uptake of Noradrenaline by Synaptosomes

19 March 2023

47

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Quantitative studies of norepinephrine uptake by synaptosomes.

19 March 2023

48

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Circadian Rhythm of Plasma 11-Hydroxycorticosteroids in Psychiatric Disorders

19 March 2023

49

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Mineral Metabolism in Affective Disorders

19 March 2023

50

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

The biochemistry of affective disorders

19 March 2023

51

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

MINERAL METABOLISM IN MELANCHOLIA.

19 March 2023

52

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

The distribution of electrolytes and water in patients after taking lithium carbonate

19 March 2023

53

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Total exchangeable sodium in depressive illness

19 March 2023

54

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Potentiation of the antidepressive effect of a monoamine-oxidase inhibitor by tryptophan

19 March 2023

55

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

CHANGES IN 5-HYDROXYTRYPTOPHAN METABOLISM IN DEPRESSION

19 March 2023

56

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Tryptamine metabolism in depression

19 March 2023

57

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

EFFECTS OF LITHIUM CARBONATE ON ELECTROLYTE DISTRIBUTION IN MAN

19 March 2023

58

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Mineral metabolism in mania.

19 March 2023

59

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Tryptophan in the treatment of depression.

19 March 2023

60

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Abnormality of the blood-cerebrospinal fluid barrier of patients suffering from a depressive illness

19 March 2023

61

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

The effect of lithium on cerebral monoamine neurons

19 March 2023

62

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Water and sodium in two psychotics.

19 March 2023

63

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Further studies on iproniazid phosphate; isonicotinil-isopropyl-hydrazine phosphate marsilid

19 March 2023

64

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Studies on the urinary excretion of 5-hydroxyindolacetic acid and 17-hydroxycorticosteroids in patients treated with marsilid

19 March 2023

66

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Clinical-pharmacological evaluation of p-chlorophenylalanine: A new serotonin-depleting agent

19 March 2023

67

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

The combined use of α-methyltyrosine and threo-dihydroxyphenylserine—selective reduction of dopamine levels in the central nervous system

19 March 2023

68

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

The relationship between affect and the excretion of adrenaline, noradrenaline, and 17-hydroxycorticosteroids.

19 March 2023

70

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Efficacy of Tranquilizing and Antidepressant Drugs

19 March 2023

71

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Metabolic variations in manic-depressive psychosis.

19 March 2023

75

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

[On the effects of L-dopa in man and their modification by reserpine, chlorpromazine, iproniazid and vitamin B6]

19 March 2023

76

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania

19 March 2023

78

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Effects of Drugs on Uptake of Isotopic Norepinephrine by Cat Tissues

19 March 2023

79

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Blood-levels of thyrotrophic hormone, protein-bound iodine, and cortisol in schizophrenia and affective states.

19 March 2023

80

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

On the chemical basis of mood

19 March 2023

81

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Cerebral amines and behaviour.

19 March 2023

82

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

19 March 2023

Methysergide in Mania

83

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Plasma cortisol levels in depression

19 March 2023

90

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Inhibition of Serotonin Synthesis by Para-Chlorophenylalanine in Patients with the Carcinoid Syndrome

19 March 2023

94

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Biochemical and pharmacologic effects of alpha-methyltyrosine in man

19 March 2023

95

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Pituitary adrenal function and depression. An outline for research

19 March 2023

99

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

A PRELIMINARY INVESTIGATION OF STEROID EXCRETION IN DEPRESSED PATIENTS BEFORE AND AFTER ELECTROL-CONVULSIVE THERAPY

19 March 2023

101

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Clinical efficacy of chlorpromazine-procyclidine combination, imipramine and placebo in depressive disorders

19 March 2023

102

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

The Differential Effect of Cortisone and of A.C.T.H. On Mood

19 March 2023

103

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Circadian rhythm of adrenal cortical activity in depression. I. A comparison of depressed patients with normal subjects.

19 March 2023

105

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Effect of ACTH in chronic lung disease; a study of five patients.

19 March 2023

106

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Effect of iproniazid on monoamines and monamine oxidase in human brain.

19 March 2023

107

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

19 March 2023

108

192

151

1964

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

The possible thymoleptic effect of the lithium ion.

19 March 2023

109

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Electrolytes and depressive illness

19 March 2023

114

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

CORTISOL SECRETION RATE IN DEPRESSIVE ILLNESS

19 March 2023

115

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Plasma cortisol in depressive illness

19 March 2023

118

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Psychotic reactions induced by corticotropin (ACTH) cortisone.

19 March 2023

119

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

19 March 2023

121

18

775

Glowinski

1966

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

19 March 2023

122

18

1201

Glowinski

1966

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Psychic effects of ACTH and cortisone.

19 March 2023

123

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

DISCLOSURE OF LABILE MONOAMINE FRACTIONS IN BRAIN AND THEIR CORRELATION TO BEHAVIOUR.

19 March 2023

125

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Depression induced by Rauwolfia compounds

19 March 2023

126

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

The action of reserpine in imipramine-resistant depressive patients. Clinical and biochemical study

19 March 2023

127

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Trial of Methysergide in Mania

19 March 2023

128

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Relationship between the Action of Monoamine Oxidase Inhibitors on the Noradrenaline Uptake System and their Antidepressant Efficacy

19 March 2023

130

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Drug therapy of depression. Amitriptyline, perphenazine, and their combination in different syndromes

19 March 2023

132

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Variations in Body Water during Recovery from Depression

19 March 2023

133

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Body Water Variations in Manic-Depressive Psychosis

19 March 2023

134

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Variations in II-Hydroxycorticosteroids in Depression and Manic-Depressive Psychosis

19 March 2023

135

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

The excretion of urinary 11-deoxy- and 11-oxy- 17-hydroxy-corticosteroids in depressive patients during basal conditions and during the administration of methopyrapone

19 March 2023

138

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Evoked release of norepinephrine and serotonin from brain slices: inhibitoon by lithium

19 March 2023

140

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

A sustained effect of electroconvulsive shock on the turnover of norepinephrine in the central nervous system of the rat

19 March 2023

141

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

The effect of the sympathomimetic amines on behaviour and electrocortical activity of the chicken

19 March 2023

142

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

CLINICAL EXPERIENCE WITH DIHYDROXYPHENYLALANINE (DOPA) IN DEPRESSION

19 March 2023

145

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Relief of depression within one day using an M.A.O. inhibitor and intravenous 5-HTP

19 March 2023

147

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

FURTHER STUDIES ON: ONE DAY TREATMENT OF DEPRESSION WITH 5-HTP

19 March 2023

148

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Circadian rhythm of plasma 11-hydroxycorticosteroids in depressive illness, congestive heart failure, and Cushing's syndrome.

19 March 2023

149

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

19 March 2023

151

16

179

Kopin

1964

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

The treatment of depressive states with G 22355 (imipramine hydrochloride).

19 March 2023

154

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

URINARY STEROIDS IN NEUROTIC- AND MANIC-DEPRESSION

19 March 2023

155

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

STEROID EXCRETION IN DEPRESSIVE DISORDERS.

19 March 2023

156

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Physiologic treatment of depressive reactions: a pilot study

19 March 2023

157

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Effects of ACTH and cortisone on mood and mentation.

19 March 2023

161

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

PLASMA HYDROCORTISONE IN MENTAL DISEASES.

19 March 2023

163

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

3-Methoxy-4-hydroxy phenylglycol (MHPG) excretion in depressive states. A pilot study.

19 March 2023

166

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Effect of D-amphetamine on rat brain noradrenaline and serotonin.

19 March 2023

167

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

EFFECT OF MONOAMINE-OXIDASE INHIBITORS ON THE CONCENTRATIONS OF 5-HYDROXYTRYPTAMINE IN THE HUMAN BRAIN

19 March 2023

168

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

The diurnal variation of plasma cortisol levels in depression

19 March 2023

169

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Amines, alerting, and affect.

19 March 2023

174

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

The effect of lithium and amphetamine on desmethylimipramine-Ro 4-1284 induced motor hyperactivity

19 March 2023

177

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

The effects of dopa on inhibited depressions

19 March 2023

178

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

INTERRELATIONSHIPS BETWEEN THE ENDOCRINE SYSTEM NEUROPSYCHIATRY.

19 March 2023

180

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

EFFECTS OF D-AMPHETAMINE AND RESTRAINT ON THE CONTENT OF NOREPINEPHRINE AND DOPAMINE IN RAT BRAIN.

19 March 2023

181

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Depression and anxiety occurring during Rauwolfia therapy.

19 March 2023

182

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Stimulation by lithium of monoamine uptake in human platelets

19 March 2023

183

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Correlation of behavior and catecholamine metabolite excretion

19 March 2023

184

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

POTENTIATION OF MONOAMINE-OXIDASE INHIBITORS BY TRYPTOPHAN

19 March 2023

185

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

A clinical and biochemical study of a trial of iproniazid in the treatment of depression

19 March 2023

187

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Differentiation of two genetically specific types of depression by the response to anti-depressants

19 March 2023

188

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Use of pituitary adrenocorticotropic hormone (ACTH) and cortisone in lymphomas and leukemias.

19 March 2023

189

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

5-hydroxytryptophan for depression

19 March 2023

190

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

COMBINED ADMINISTRATION OF DESIPRAMINE AND RESERPINE OR TETRABENAZINE IN DEPRESSIVE PATIENTS

19 March 2023

192

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

NOREPINEPHRINE: A POSSIBLE EXCITATORY NEUROHORMONE OF THE REWARD SYSTEM.

19 March 2023

193

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

The systolic blood pressure response of depressed patients to infused norepinephrine

19 March 2023

194

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

THE RELATIONSHIP BETWEEN 17-HYDROXYCORTICOSTEROID EXCRETION AND GLUCOSE UTILIZATION IN DEPRESSIONS.

19 March 2023

196

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Mental disturbances associated with ACTH and cortisone: a review of explanatory hypotheses

19 March 2023

197

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Psychological concomitants of cortisone and ACTH therapy.

19 March 2023

198

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Brain Catecholamines: Relation to the Defense Reaction Evoked by Amygdaloid Stimulation in Cat.

19 March 2023

199

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Regulation of urinary steroid excretion; spontaneous changes in the pattern of daily excretion in mental patients

19 March 2023

200

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Concurrent observations of behavior changes and of adrenocortical variations in a cyclothymic patient during a period of 12 months.

19 March 2023

201

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Psychological response to corticotropin, cortisone, and related steroid substances; psychotic reaction types.

19 March 2023

203

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Differences in the metabolism of norepinephrine in depressions. The effects of various therapies.

19 March 2023

204

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Interrelationships between electroshock, the blood-brain barrier, and catecholamines

19 March 2023

205

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Accumulation of tritiated 5-hydroxytryptamine in brain slices.

19 March 2023

206

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Corticosteroids in depressive illness. II. A longitudinal psychoendocrine study

19 March 2023

209

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

PSYCHOENDOCRINE ASPECTS OF ACUTE SCHIZOPHRENIC REACTIONS

19 March 2023

210

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Corticosteroid responses to psychotherapy of depressions. I. Evaluations during confrontation of loss.

19 March 2023

211

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

The effects of psychoactive drugs on norepinephrine-3H metabolism in brain

19 March 2023

214

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite

19 March 2023

215

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

The catecholamine hypothesis of affective disorders: a review of supporting evidence

19 March 2023

217

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Biochemical and pressor effects of oral D,L-dihydroxy-phenylalanine in patients pretreated with antidepressant drugs

19 March 2023

218

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

EXCRETION OF 3-METHOXY-4-HYDROXYMANDELIC ACID (VMA) IN DEPRESSED PATIENTS TREATED WITH ANTIDEPRESSANT DRUGS

19 March 2023

219

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Catecholamine metabolism in affective disorders. I. Normetanephrine and VMA excretion in depressed patients treated with imipramine

19 March 2023

220

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Normetanephrine Excretion and Affective State in Depressed Patients Treated with Imipramine

19 March 2023

221

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

The effects of lithium ion on H3 -norepinephrine metabolism in brain

19 March 2023

222

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Norepinephrine metabolism and drugs used in the affective disorders: a possible mechanism of action.

19 March 2023

223

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Mood, motility and 17-hydroxycorticoid excretion; a polyvariable case study.

19 March 2023

226

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

A COMPARISON OF MODALINE SULFATE (W 3207B) AND IMIPRAMINE IN THE TREATMENT OF DEPRESSION

19 March 2023

227

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Mineral metabolism, mania, and melancholia

19 March 2023

228

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Potassium and Water Distribution in Depression

19 March 2023

229

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

5-Hydroxytryptamine in the Hind-Brain of Depressive Suicides

19 March 2023

230

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Pharmacological Studies with Tofrānil

19 March 2023

232

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Inhibition of catecholamine synthesis in man with alpha-methyl-tyrosine, an inhibitor of tyrosine hydroxylase

19 March 2023

234

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Catecholamine Excretion in Manic-Depressive and Schizophrenic Psychosis and its Relationship to Symptomatology

19 March 2023

235

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Nervous and mental disorders in Cushing's syndrome.

19 March 2023

237

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Therapeutic effect of pituitary adrenocorticotropic hormone (ACTH) in a case of Henoch-Schönlein vascular (anaphylactoid) purpura

19 March 2023

238

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Depression and anxiety ratings in relation to the excretion of urinary total 17-OHCS in depressive subjects

19 March 2023

240

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

19 March 2023

241

9

210

Stern

1967

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Humoral changes in manic-depressive psychosis with particular reference to the excretion of catechol amines in urine

19 March 2023

242

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

19 March 2023

245

9

213

Sulser

1967

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Neuropsychiatric aspects of Cushing's syndrome

19 March 2023

246

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Tryptamine Receptors in the Central Nervous System

19 March 2023

250

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Influencing the human indoleamine metabolism by means of a chlorinated amphetamine derivative with antidepressive action (p-Chloro-N-Methylamphetamine)

19 March 2023

251

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Effect of marsilid on excretion of 3-methoxy-4-hydroxymandelic acid in man

19 March 2023

252

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Propranolol-induced depression

19 March 2023

253

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Amines, alerting and affect.

19 March 2023

254

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

Blood-brain barrier for adrenaline.

19 March 2023

255

1 reference

https://api.crossref.org/works/10.1016/S0074-7742(08)60060-4

19 March 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4918142

19 March 2023

1 reference